Results 131 to 140 of about 145,853 (310)

A Case of Drug‐Induced Pancreatitis

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Drug‐induced pancreatitis (DIP) is a rare but important cause of acute abdominal pain, and ciprofloxacin‐associated cases are exceptionally uncommon. We report a 35‐year‐old woman with no significant medical history who developed severe epigastric pain radiating to the back, accompanied by nausea and vomiting, 3 days after initiating self ...
Muskan Shrestha   +5 more
wiley   +1 more source

A Case Report on Disseminated Mycobacterium avium Complex Infection in an Otherwise Healthy Individual—A Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Disseminated Mycobacterium avium complex (MAC) infection can mimic tuberculosis (TB) in immunocompetent individuals, leading to diagnostic and therapeutic challenges. Clinicians should consider nontuberculous mycobacteria (NTM) in patients unresponsive to anti‐tubercular therapy (ATT), especially in endemic regions.
Abdulla Bin Hridoy   +7 more
wiley   +1 more source

Microbial Gene Profiling and Targeted Metabolomics in Fecal Samples of Dogs With Chronic Enteropathy With or Without Increased Dysbiosis Index

open access: yesJournal of Veterinary Internal Medicine
Background In previous studies, only a subset of dogs with chronic enteropathy (CE) had an increased dysbiosis index (DI) or altered fecal metabolites or both, suggesting differences in underlying intestinal pathophysiology between these subsets ...
Chih‐Chun Chen   +13 more
doaj   +1 more source

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study

open access: yesMedComm, Volume 7, Issue 2, February 2026.
Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang   +17 more
wiley   +1 more source

Supplementation of Vitamin K1 in Dogs With Chronic Enteropathy

open access: yesJournal of Veterinary Internal Medicine
Background Information regarding measurement and supplementation of vitamin K1 (vitK1) in dogs with chronic enteropathy (CE) is limited. Hypothesis/Objectives Compare vitK1 concentrations of healthy dogs to dogs with CE and determine if supplementation ...
Jillian Myers Smith   +4 more
doaj   +1 more source

Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial

open access: yesUnited European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background and Aims Remimazolam, a new ultra‐short‐acting benzodiazepine, is a safe and effective option for procedural sedation. Nevertheless, to date, no study has directly compared remimazolam and midazolam in diagnostic upper gastrointestinal endoscopy. This study aimed to evaluate the efficacy and safety of remimazolam compared with those
Yehyun Park   +7 more
wiley   +1 more source

What is the cost of delayed diagnosis of bile acid malabsorption?

open access: diamond, 2019
Darren Fernandes   +3 more
openalex   +1 more source

Nutritional approach in a growing Jack Russell terrier with gall bladder agenesis

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract An asymptomatic male Jack Russell terrier diagnosed at the age of 18 weeks with congenital gall bladder agenesis, confirmed by computed tomography scan, after finding abnormally high values for liver enzymes in a routine blood count. Treatment with liver‐protective agents S‐adenosylmethionine and ursodeoxycholic acid was initiated. At 6 months
Tamara Seghers   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy